12 related news articles for Lung cancer
-
New treatment promises to increase lung cancer survival
Researchers at Hudson Institute of Medical Research have shown a new drug that is incredibly effective in treating small cell lung cancer – doubling the usual survival time.… Read more
-
Combatting a killer – understanding what causes small cell lung cancer
A new understanding of the causes of small cell lung cancer (SCLC) could lead to more personalised treatments and lower mortality from this deadly disease.… Read more
-
Hudson Institute 2021 Emerging Leaders announced
Six Early Career Researchers have been chosen for the 2021 Hudson Institute Emerging Leaders program.… Read more
-
Link between COPD, emphysema and lung cancer could lead to new treatments
Hudson Institute scientists have paved the way to potentially test new treatments for chronic obstructive pulmonary disease (COPD) and emphysema, following a discovery of the molecular drivers of these lung diseases.… Read more
-
Cancer Council Victoria Postdoctoral Fellowship awarded to progress lung cancer research
Congratulations to Dr Mohamed Saad, who has been awarded a Cancer Council Victoria (CCV) Postdoctoral Cancer Research Fellowship to inform the design of better treatment approaches in lung cancer.… Read more
-
Mid-career researcher recognised by the Victorian Cancer Agency
Congratulations to Dr Daniel Gough for receiving a Mid-Career Research Fellowship from the Victorian Cancer Agency (VCA) for his research in developing new therapies for small cell lung cancer (SCLC).… Read more
-
Mistaken identity: new mechanism behind stomach cancer identified
Improved treatments for a range of cancers could be possible following a discovery that stomach cancer is mainly driven by a different process than previously believed.… Read more
-
Drug may be breakthrough to treat lung cancer
The development of a drug to treat the most common type of lung cancer is a step closer … Read more
-
Turbo-charging chemotherapy for lung cancer
A naturally occurring hormone could help make chemotherapy much more effective for many Australians with lung cancer, according to new findings from Sydney and Melbourne researchers. And the hormone – known as follistatin – also appears to prevent kidney damage, a serious side effect of chemotherapy. The promising new ‘two birds, one stone’ treatment approach, which was… Read more
-
Researchers identify key driver of devastating muscle wasting disease affecting cancer patients
Lung cancer is the leading cause of cancer death worldwide, and is frequently associated with cachexia. Cachexia is a devastating syndrome of weight and muscle wasting, affecting as many as 80 per cent of advanced cancer patients.… Read more
-
International ICI delegates tour Monash Health Translation Precinct
Scientists from across the world discussing immunology research… Read more
-
Double blow for lung cancer and emphysema offers hope to patients
Lung cancer and emphysema could be diagnosed earlier and targeted with an existing drug, vastly improving patient outcomes, researchers at Hudson Institute of Medical Research have discovered… Read more